Heterogeneous disease omics explores diverse molecular profiles across patients, guiding personalized diagnostics and therapies.

By integrating genomics, transcriptomics, and proteomics, researchers reveal unique disease pathways, improving prognosis and tailoring treatments to individual biological signatures.